We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+32.93%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$137M
AUM Growth
-$252M
Cap. Flow
-$274M
Cap. Flow %
-200.36%
Top 10 Hldgs %
12.88%
Holding
642
New
208
Increased
25
Reduced
68
Closed
338

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$2.84M
2
LHX icon
L3Harris
LHX
+$2.33M
3
XLNX
Xilinx Inc
XLNX
+$1.66M
4
BABA icon
Alibaba
BABA
+$1.46M
5
ZBH icon
Zimmer Biomet
ZBH
+$1.39M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$6.29M
2
ABT icon
Abbott
ABT
+$6.26M
3
V icon
Visa
V
+$6.25M
4
VZ icon
Verizon
VZ
+$6.22M
5
WFC icon
Wells Fargo
WFC
+$5.82M

Sector Composition

Rank Sector Weight
1 Technology 18.17%
2 Healthcare 14.15%
3 Industrials 11.71%
4 Consumer Discretionary 11.29%
5 Consumer Staples 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXS icon
151
AXIS Capital
AXS
$7.68B
$349K 0.26%
8,600
+1,000
+13% +$38.5K
CROX icon
152
Crocs
CROX
$6.14B
$348K 0.25%
+9,462
New +$250K
OTEX icon
153
Open Text
OTEX
$6.15B
$348K 0.25%
+8,200
New +$325K
CHGG icon
154
Chegg
CHGG
$110M
$346K 0.25%
+5,142
New +$275K
NXPI icon
155
NXP Semiconductors
NXPI
$57.8B
$342K 0.25%
+3,001
New +$300K
CHNG
156
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$341K 0.25%
+30,469
New +$342K
UL icon
157
Unilever
UL
$137B
$340K 0.25%
+5,515
New +$330K
EDU icon
158
New Oriental
EDU
$9.37B
$339K 0.25%
2,600
-7,100
-73% -$865K
LPX icon
159
Louisiana-Pacific
LPX
$5.06B
$339K 0.25%
13,200
-11,700
-47% -$248K
FLO icon
160
Flowers Foods
FLO
$1.49B
$338K 0.25%
+15,100
New +$340K
PTC icon
161
PTC
PTC
$15.8B
$338K 0.25%
4,339
+200
+5% +$14.2K
MAXR
162
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$338K 0.25%
+18,800
New +$243K
EXC icon
163
Exelon
EXC
$47.2B
$335K 0.25%
+12,938
New +$344K
KNX icon
164
Knight Transportation
KNX
$11.3B
$334K 0.24%
+8,000
New +$305K
LH icon
165
Labcorp
LH
$25B
$332K 0.24%
+2,328
New +$322K
GWPH
166
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$331K 0.24%
+2,700
New +$306K
PODD icon
167
Insulet
PODD
$11.5B
$330K 0.24%
+1,700
New +$325K
MRNA icon
168
Moderna
MRNA
$21.8B
$329K 0.24%
+5,123
New +$281K
WM icon
169
Waste Management
WM
$90.6B
$328K 0.24%
3,095
-11,905
-79% -$1.2M
LOPE icon
170
Grand Canyon Education
LOPE
$3.79B
$326K 0.24%
+3,600
New +$320K
AIG icon
171
American International
AIG
$41.7B
$325K 0.24%
10,416
-60,284
-85% -$1.69M
ASND icon
172
Ascendis Pharma A/S
ASND
$16B
$325K 0.24%
2,200
GOTU icon
173
Gaotu Techedu
GOTU
$434M
$324K 0.24%
+5,395
New +$214K
AWK icon
174
American Water Works
AWK
$26.7B
$322K 0.24%
+2,500
New +$311K
CL icon
175
Colgate-Palmolive
CL
$73.1B
$322K 0.24%
+4,400
New +$313K

Similar funds

Seven Eight Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Seven Eight Capital held 642 positions worth $137M, down 65% from $389M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital withdrew a net $274M in Q2 2020, closing 338 positions and reducing 68 holdings. Its most notable exit was Salesforce, an estimated $6.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Seven Eight Capital opened a new position in Conagra Brands worth $2.99M.

  • Seven Eight Capital's largest Q2 2020 buy was Conagra Brands: 85,100 shares worth $2.99M.
  • Seven Eight Capital added most to Xilinx Inc in Q2 2020, an estimated $1.66M increase.
  • Seven Eight Capital's biggest Q2 2020 reduction was Chevron, cutting an estimated $5.48M.
  • Seven Eight Capital fully exited Salesforce in Q2 2020, selling an estimated $6.29M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $137M portfolio in Q2 2020.
  • Seven Eight Capital opened 208 new positions and closed 338 in Q2 2020.
  • Seven Eight Capital's portfolio value fell 65% quarter-over-quarter to $137M.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.